Skip to main content
Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
24.08
-0.72 (-2.90%)
At close: Mar 6, 2026, 4:00 PM EST
24.85
+0.77 (3.20%)
After-hours: Mar 6, 2026, 6:50 PM EST

Zymeworks Revenue

In the year 2025, Zymeworks had annual revenue of $105.97M with 38.87% growth. Zymeworks had revenue of $2.52M in the quarter ending December 31, 2025, a decrease of -91.90%.

Revenue (ttm)
$105.97M
Revenue Growth
+38.87%
P/S Ratio
16.76
Revenue / Employee
$401,383
Employees
264
Market Cap
1.78B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025105.97M29.66M38.87%
Dec 31, 202476.30M292.00K0.38%
Dec 31, 202376.01M-336.47M-81.57%
Dec 31, 2022412.48M385.80M1,446.03%
Dec 31, 202126.68M-12.27M-31.50%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vericel 276.26M
Iovance Biotherapeutics 263.50M
Syndax Pharmaceuticals 172.35M
Recursion Pharmaceuticals 74.68M
Relay Therapeutics 15.36M
Revenue Rankings

ZYME News

More News